Sign Out
Treatment of postmenopausal women with estrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant anti-estrogen therapy or disease progression on therapy with an anti-estrogen.
Treatment of estrogen receptor-positive, human epidermal growth receptor 2 (HER2) - negative locally advanced or metastatic breast cancer in postmenopausal women not previously treated with endocrine therapy.
